SECsense Logo

Immuron Limited's Form 6-K: Travelan Clinical Trial Update & Compliance Insights

$IMRN
Form 6-K
Filed on: 2025-01-14
Source
Immuron Limited's Form 6-K: Travelan Clinical Trial Update & Compliance Insights

Here are the key points extracted from the financial report of Immuron Limited (Form 6-K):

  1. Filing Details:
  • Type: Report of Foreign Private Issuer (Form 6-K).
  • Commission File Number: 001-38104.
  • Date of Report: January 14, 2025.
  1. Registrant Information:
  • Company Name: Immuron Limited.
  • Address: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
  1. Compliance:
  • The registrant indicated it does not file annual reports under Form 20-F but could file under Form 40-F (marked as "No").
  • They confirmed that the information provided does not constitute a filing under the Securities Exchange Act of 1934.
  1. Explanatory Note:
  • Immuron Limited published a notice titled "Immuron Announces Travelan Clinical Trial Update" on the Australian Securities Exchange on January 14, 2025.
  • The notice is attached as an exhibit to this Form 6-K.
  1. Exhibits:
  • Exhibit 99.1: A copy of the public notice regarding the clinical trial update.
  1. Signatory:
  • The report is signed by Phillip Hains, Company Secretary of Immuron Limited, confirming the accuracy of the information.

This report provides essential insights into the company's compliance and recent updates related to its clinical trials, which may influence investor sentiment and market behavior.